Large-scale pathways-based association study in amyotrophic lateral sclerosis.

Large-scale pathways-based association study in amyotrophic lateral sclerosis.

Показать другие версии (1)

Sporadic amyotrophic lateral sclerosis (ALS), a devastating neurodegenerative disease, most likely results from complex genetic and environmental interactions. Although a number of association studies have been performed in an effort to find genetic components of sporadic ALS, most of them resulted...

Полное описание

Библиографические подробности
Главные авторы:	Kasperaviciute, D, Weale, M, Shianna, K, Banks, G, Simpson, C, Hansen, V, Turner, M, Shaw, C, Al-Chalabi, A, Pall, H, Goodall, E, Morrison, K, Orrell, R, Beck, M, Jablonka, S, Sendtner, M, Brockington, A, Ince, P, Hartley, J, Nixon, H, Shaw, P, Schiavo, G, Wood, N, Goldstein, D, Fisher, E
Формат:	Journal article
Язык:	English
Опубликовано:	2007

Схожие документы

Large-scale pathways-based association study in amyotrophic lateral sclerosis
по: Kasperavičiute, D, и др.
Опубликовано: (2007)

Screening of the transcriptional regulatory regions of vascular endothelial growth factor receptor 2 (VEGFR2) in amyotrophic lateral sclerosis
по: Hartley Judith, и др.
Опубликовано: (2007-04-01)

Geographical clustering of amyotrophic lateral sclerosis in South-East England: a population study.
по: Scott, K, и др.
Опубликовано: (2009)

The sex ratio in amyotrophic lateral sclerosis: A population based study.
по: Manjaly, Z, и др.
Опубликовано: (2010)

Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis.
по: Turner, M, и др.
Опубликовано: (2002)

Downregulation of genes with a function in axon outgrowth and synapse formation in motor neurones of the VEGF<sup>δ/δ </sup>mouse model of amyotrophic lateral sclerosis
по: Lambrechts Diether, и др.
Опубликовано: (2010-03-01)

Volumetric cortical loss in sporadic and familial amyotrophic lateral sclerosis.
по: Turner, M, и др.
Опубликовано: (2007)

Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: A cross-sectional study
по: Majounie, E, и др.
Опубликовано: (2012)

Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study.
по: Majounie, E, и др.
Опубликовано: (2012)

A proposed staging system for amyotrophic lateral sclerosis.
по: Roche, J, и др.
Опубликовано: (2012)

The use of biotelemetry to explore disease progression markers in amyotrophic lateral sclerosis
по: Kelly, M, и др.
Опубликовано: (2020)

A multicentre evaluation of oropharyngeal secretion management practices in amyotrophic lateral sclerosis
по: McGeachan, AJ, и др.
Опубликовано: (2016)

Controversies and priorities in amyotrophic lateral sclerosis.
по: Turner, M, и др.
Опубликовано: (2013)

Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials.
по: Balendra, R, и др.
Опубликовано: (2015)

Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials
по: Balendra, R, и др.
Опубликовано: (2015)

REM sleep physiology and selective neuronal vulnerability in amyotrophic lateral sclerosis
по: Turner, M, и др.
Опубликовано: (2020)

Insulin-like growth factor 1 in diabetic neuropathy and amyotrophic lateral sclerosis
по: Stefanie Rauskolb, и др.
Опубликовано: (2017-01-01)

Lipid-mediated resolution of inflammation and survival in amyotrophic lateral sclerosis
по: Yildiz, O, и др.
Опубликовано: (2025)

Amyotrophic lateral sclerosis in an urban setting: a population based study of inner city London.
по: Johnston, C, и др.
Опубликовано: (2006)

Mutations in the vesicular trafficking protein annexin A11 are associated with amyotrophic lateral sclerosis
по: Smith, BN, и др.
Опубликовано: (2017)

Evolution of white matter damage in amyotrophic lateral sclerosis
по: Gabel, M, и др.
Опубликовано: (2020)

Estimating clinical stage of amyotrophic lateral sclerosis from the ALS Functional Rating Scale.
по: Balendra, R, и др.
Опубликовано: (2014)

Ciliary neurotrophic factor genotype does not influence clinical phenotype in amyotrophic lateral sclerosis.
по: Al-Chalabi, A, и др.
Опубликовано: (2003)

Health utility decreases with increasing clinical stage in amyotrophic lateral sclerosis.
по: Jones, A, и др.
Опубликовано: (2014)

Mutations in the vesicular trafficking protein annexin A11 are associated with amyotrophic lateral sclerosis
по: Smith, B, и др.
Опубликовано: (2017)

Amyotrophic lateral sclerosis and cerebellum
по: Renata Kabiljo, и др.
Опубликовано: (2022-07-01)

Concordance between site of onset and limb dominance in amyotrophic lateral sclerosis.
по: Turner, M, и др.
Опубликовано: (2011)

Therapy development for spinal muscular atrophy: perspectives for muscular dystrophies and neurodegenerative disorders
по: Sibylle Jablonka, и др.
Опубликовано: (2022-01-01)

Young-onset amyotrophic lateral sclerosis: Historical and other observations
по: Turner, M, и др.
Опубликовано: (2012)

Young-onset amyotrophic lateral sclerosis: historical and other observations.
по: Turner, M, и др.
Опубликовано: (2012)

Mechanisms, models and biomarkers in amyotrophic lateral sclerosis.
по: Turner, M, и др.
Опубликовано: (2013)

Quantifying disease progression in amyotrophic lateral sclerosis.
по: Simon, N, и др.
Опубликовано: (2014)

Relation between cognitive dysfunction and pseudobulbar palsy in amyotrophic lateral sclerosis.
по: Abrahams, S, и др.
Опубликовано: (1997)

Objectively monitoring amyotrophic lateral sclerosis patient symptoms during clinical trials with sensors: Observational study
по: Garcia-Gancedo, L, и др.
Опубликовано: (2019)

Amyotrophic lateral sclerosis and cancer: a register-based study in Sweden.
по: Fang, F, и др.
Опубликовано: (2013)

NEK1 variants confer susceptibility to amyotrophic lateral sclerosis
по: Kenna, P, и др.
Опубликовано: (2016)

Protocol for a double-blind randomised placebo-controlled trial of lithium carbonate in patients with amyotrophic Lateral Sclerosis (LiCALS) [Eudract number: 2008-006891-31]
по: Kelly Joanna, и др.
Опубликовано: (2011-09-01)

Stiff person syndrome associated anti-amphiphysin antibodies reduce GABA associated [Ca2+]i rise in embryonic motoneurons
по: C. Geis, и др.
Опубликовано: (2009-10-01)

Analysis of terms used for the diagnosis and classification of amyotrophic lateral sclerosis and motor neuron disease
по: Rutter-Locher, Z, и др.
Опубликовано: (2016)

The role of copy number variation in susceptibility to amyotrophic lateral sclerosis: genome-wide association study and comparison with published loci.
по: Louise V Wain, и др.
Опубликовано: (2009-12-01)